drugset / Trial / NCT02506257

Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects

NCT02506257 ↗

Phase 1 Completed 90 enrolled SIFI SpA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized, double-masked, placebo-controlled, multiple center, parallel-group Phase 1 study to evaluate the safety and tolerability of 3 doses of preservative-free PHMB ophthalmic solution compared to placebo in healthy subjects

Timeline

Start
2015-11
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Polyhexamethyl biguanide Unknown 0.04 % Topical
Subject Polyhexamethyl biguanide Unknown 0.06 % Topical
Subject Polyhexamethyl biguanide Unknown 0.08 % Topical